Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom

Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom

Dionne CW Braeken,1–3 Gernot GU Rohde,2 Frits ME Franssen,1,2 Johanna HM Driessen,3–5 Tjeerd P van Staa,3,6 Patrick C Souverein,3 Emiel FM Wouters,1,2 Frank de Vries3,4,7 1Department of Research and Education, CIRO, Horn, 2Department of Respiratory Medicine, Maastricht Universit...

Full description

Bibliographic Details
Main Authors:	Braeken DCW, Rohde GGU, Franssen FME, Driessen JHM, van Staa TP, Souverein PC, Wouters EFM, de Vries F
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-08-01
Series:	International Journal of COPD
Subjects:	Chronic Obstructive Pulmonary Disease (COPD) community-acquired pneumonia (CAP) smoking status
Online Access:	https://www.dovepress.com/risk-of-community-acquired-pneumonia-in-chronic-obstructive-pulmonary--peer-reviewed-article-COPD

Similar Items

Sputum microbiology predicts health status in COPD
by: Braeken DCW, et al.
Published: (2016-11-01)

Upregulated pneumococcal adhesion molecule (platelet-activating factor receptor) may predispose COPD patients to community-acquired pneumonia
by: Shukla SD, et al.
Published: (2017-10-01)

CAPPRIC Study—Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings
by: Jesús Molina, et al.
Published: (2021-02-01)

Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012
by: Roger Dumke, et al.
Published: (2015-03-01)

Pattern of community acquired pneumonia in pregnant ladies in Ain Shams University hospitals
by: Aya M. Abdel Dayem, et al.
Published: (2012-10-01)

Pattern of community and hospital acquired pneumonia in Egyptian military hospitals
by: Magdy Mohammad Khalil, et al.
Published: (2013-01-01)

Community acquired pneumonia: a cost-of-illness analysis in Greece
by: Panagiota Naoum, et al.
Published: (2020-06-01)

Effectiveness of 3rd generation cephalosporin compare to 3rd generation cephalosporin - macrolides for community acquired pneumonia patients in PKU Muhammadiyah Yogyakarta Hospital
by: Muhammad Dwi Suprobo, et al.
Published: (2019-11-01)

Etiology of community-acquired pneumonia in adults: a systematic review
by: Saeed Shoar, et al.
Published: (2020-10-01)

A study of serum phosphate levels and its correlation with curb-65 score in community acquired pneumonia
by: Nitish Ashok Gurav, et al.
Published: (2021-05-01)

Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
by: Polsky Daniel, et al.
Published: (2012-10-01)

Molecular etiological profile of atypical bacterial pathogens, viruses and coinfections among infants and children with community acquired pneumonia admitted to a national hospital in Lima, Peru
by: del Valle-Mendoza, Juana, et al.
Published: (2017)

Features Discriminating COVID-19 From Community-Acquired Pneumonia in Pediatric Patients
by: Yu Guo, et al.
Published: (2020-11-01)

Medical Expenditures of Community- Acquired Pneumonia Hospitalization: A Two-Year Retrospective Study from a Hospital Electronic Database in Vietnam
by: Trung Quang Vo, et al.
Published: (2018-06-01)

Modern approaches to the rational choice of antibiotic for treatment of community-acquired pneumonia in various categories of patients
by: S. K. Zyryanov, et al.
Published: (2019-08-01)

Assessment of thoracic ultrasound in complementary diagnosis and in follow up of community-acquired pneumonia (cap)
by: Maria D’Amato, et al.
Published: (2017-08-01)

Study of Absolute Neutrophil Absolute Lymphocyte count ratio in Community Acquired Pneumonia patients as a prognostic indicator at a tertiary care centre
by: Dyaneshwar Nirgude, et al.
Published: (2021-09-01)

Molecular detection of Mycoplasma pneumoniae by quantitative real-time PCR in patients with community acquired pneumonia
by: Rama Chaudhry, et al.
Published: (2013-01-01)

Domain-specific cognitive impairment in patients with COPD and control subjects
by: Cleutjens FAHM, et al.
Published: (2016-12-01)

INFLAMMATION ROLE IN FORMATION OF EARLY DISTURBANCES OF A FUNCTIONAL CONDITION OF A LIVER AT COMMUNITY — ACQUIRED PNEUMONIA (LITERATURE REVIEW)
by: A. Yu. Gorbunov, et al.
Published: (2018-10-01)

Molecular etiological profile of atypical bacterial pathogens, viruses and coinfections among infants and children with community acquired pneumonia admitted to a national hospital in Lima, Peru
by: Juana del Valle-Mendoza, et al.
Published: (2017-12-01)

Antibiotic Use and Treatment Outcomes among Children with Community-Acquired Pneumonia Admitted to a Tertiary Care Public Hospital in Nepal
by: Bhishma Pokhrel, et al.
Published: (2021-04-01)

Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease
by: Lin SH, et al.
Published: (2016-12-01)

Effects of Prone Position on Inflammatory Markers in Patients with ARDS Due to Community-acquired Pneumonia
by: Ming-Cheng Chan, et al.
Published: (2007-09-01)

Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records
by: Williams NP, et al.
Published: (2017-01-01)

Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease
by: Wouters EFM, et al.
Published: (2011-09-01)

The associations of serum S100A9 with the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study
by: Hong-Yan Liu, et al.
Published: (2021-04-01)

32 year old man with "community-acquired' pneumonia
by: Jill K. Gersh, et al.
Published: (2014-04-01)

Immune mechanisms of community-acquired pneumonia and copd due to infectious etiology and methods of immunotherapy
by: E. S. Korovkina, et al.
Published: (2019-08-01)

In vitro activity of ceftobiprole against key pathogens associated with pneumonia in hospitalized patients: results from the PEG surveillance study, 2010
by: Kresken, Michael, et al.
Published: (2015-10-01)

Antibiotics and community-acquired lower respiratory tract infections. To whom? Which one?
by: Sinopalnikov A.I.
Published: (2019-02-01)

Community-acquired pneumonia in the United Kingdom: a call to action
by: James Chalmers, et al.
Published: (2017-10-01)

Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD
by: Nicholas P. Williams, et al.
Published: (2018-07-01)

The use of wearable technology to monitor physical activity in patients with COPD: a literature review
by: Pericleous P, et al.
Published: (2019-06-01)

Effect of adjunctive single high-dose vitamin D3 on outcome of community-acquired pneumonia in hospitalised adults: The VIDCAPS randomised controlled trial
by: Sandy Slow, et al.
Published: (2018-09-01)

Dilemma of community-acquired pneumonia
by: Lamia H Shaaban
Published: (2019-01-01)

Enhanced surveillance for severe pneumonia, Thailand 2010–2015
by: Charatdao Bunthi, et al.
Published: (2019-05-01)

Severe community-acquired pneumonia
by: Potgieter, Peter Daniel
Published: (2018)

Severe community-acquired pneumonia
by: Potgieter, Peter Daniel
Published: (2017)

COPD: the patient perspective
by: Jones PW, et al.
Published: (2016-02-01)